Tag Archive for: Pandemic

The world has come to a complete standstill due to the COVID-19 pandemic. Many industries, companies and businesses have been affected by this, compelling them to restructure the way business is conducted. The global mobility and relocation industries are some of the industries that have been severely impacted by the global pandemic. This in turn has affected the mobility industry, ultimately affecting the relocation industry. Relocation Africa, mobility, relocation, and immigration business has been largely affected by this pandemic.

In efforts to combat the spread of the virus and ensure the safety of their citizens, states have enforced bolder border entry restrictions, travel bans, and quarantine adherences. This has made managing the expatriate and international assignee workforce complex and challenging. Relocation Africa, situated in a continent that has been administered severe travel restrictions from third world countries while undergoing a slow vaccine rollout. Relocation Africa provides a variety of Mobility, Immigration, Research, Remuneration and Expatriate Tax services across the continent of Africa, assisting individuals and corporate clients settle into new environments as efficiently as possible.

The mobility, immigration and relocation industry has had to change the way they conduct business, to resort to flexible and remote ways in engaging their mobile expatriates and international assignees. At Relocation Africa has had to change their normal procedure/ operations of mobility and relocation to accommodate the travel restrictions and their clients.

Relocation Africa has flexed all its programs. Adding new services such as remote packing up for clients, remotely or virtually selling products for countries who are not in the country, conducts virtual and adjusted services such as opening bank accounts to allow expatriates to do this more remotely. Relocation Africa has also extended its online platforms to include more information that is readily available to its clients. Relocation Africa has also had to ensure that all training and expectation management has considered COVID-19 protocols and to ensure each assignee safe and prioritised. We have also attempted to communicate more extensively to all our clients as we cover a large geography with very different regulations, border closing and re-opening, as well as immigration regulations that are adjusting as the pandemic changes.  We would like you to connect with us on LinkedIn, Instagram, or Twitter to ensure you are getting our updates on service offerings as well as travel updates and border regulations.






Please enter your email, so we can follow up with you.

The injections of the single-dose Johnson & Johnson COVID-19 vaccine has come to a sudden halt in various countries across the continent due to rare blood-clotting syndrome emerging in six recipients.

The six recipients were all women between the ages of 18 and 48, and all developed the illness within one to three weeks of being vaccinated. All the six women who suffered what is called ‘cerebral venous sinus thrombosis’ are reported to have had low platelet counts. Frontline experts hypothesize that the vaccine activates platelets and leads to blood clots in channels that help transmit blood away from the brain. The blood clots can cause strokes or damage to the brain.

Action taken by European and Northern American states                                                                                                 

On the 9th of April 2021, the European Medicine Agency (EMA) announced its Pharmacovigilance Risk Assessment Committee (PRAC) were reviewing the Janssen COVID-10 vaccine safety signals, following reports of blood-clotting occurrences in four recipients of the Janssen vaccine in the USA. On 13th April 2021, due to concerns over the Janssen vaccine, the United States Centers for Disease Control and Prevention (US CDC) and Food and Drug Administration (FDA) has recommended a halt in the administering of the COVID-19 vaccine.

The Janssen COVID-19 vaccine in African states

In a statement to African Union (AU) Member States, the African Centre for Disease Control and Preparation (Africa CDC) issued a statement consolidating the J&J vaccine predicament in Africa. The Africa Regulatory Taskforce has endorsed the Emergency Use Authorization for the Janssen COVID-19 vaccine.

At present, South Africa is the only member state permitting the Janssen COVID-19 vaccine. Registered by the South African Health Products Regulatory Authority (SAHPRA), over 290 000 doses have been administered. On 13th April 2021, South African Health Minister, Dr Zweli Mkhize announced that the country had no reports of any blood clots following the administering of the Janssen COVID-19 vaccine. As a precautionary measure, South Africa has announced that the rollout of the vaccine will be halted to review and assess the situation alongside global regulatory authorities.

Recommendations from the Africa CDC to the AU Member States

The Africa CDC states, “As such rapid access to safe and effective vaccines is paramount to the African Union vaccination strategy to achieve control of the pandemic. Africa CDC will continue to monitor reports of adverse events following immunization, for all COVID-19 vaccines, including the Janssen COVID-19 vaccine, and will provide further guidance to Member States.”


For information as to how Relocation Africa can help you with your Mobility, Immigration, Research, Remuneration, and Expat Tax needs, email info@relocationafrica.com, or call us on +27 21 763 4240.

16 April 2021| by Sisipho Ntsabo                                                                   Relocation Africa